Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.


  • Thermo Fisher Scientific Inc. has established itself as a leader in their industry.
  • Their revenue, margins, and returns are still experiencing a small amount of post-pandemic renormalization.
  • With a calculated a PEGY of 2.979x, and an Inverted PEGY of 0.3357x, it appears to be currently overvalued.
  • I presently rate TMO a Hold.
Thermo Fisher Scientific location. Thermo Fisher offers controlled and sustained release solid oral dosage forms.



With the Fed diligently working to destroy the wealth effect and the bond market inverted for months now, I have been watching for upcoming opportunities to buy good companies at attractive valuations.

Thermo Fisher Scientific Inc. (NYSE:TMO) has

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Leave a Reply

Your email address will not be published. Required fields are marked *